Omada Health (NASDAQ:OMDA) Coverage Initiated at Evercore ISI

Research analysts at Evercore ISI began coverage on shares of Omada Health (NASDAQ:OMDA) in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm set an “outperform” rating and a $21.00 price target on the stock. Evercore ISI’s target price indicates a potential upside of 16.02% from the stock’s previous close.

Several other equities analysts have also commented on OMDA. Barclays assumed coverage on Omada Health in a research report on Tuesday. They set an “overweight” rating and a $21.00 price objective on the stock. JPMorgan Chase & Co. started coverage on shares of Omada Health in a research report on Tuesday. They set an “overweight” rating and a $19.00 price target on the stock. Needham & Company LLC started coverage on shares of Omada Health in a research note on Tuesday. They set a “buy” rating and a $23.00 price target on the stock. Wall Street Zen raised shares of Omada Health to a “hold” rating in a research note on Monday, June 16th. Finally, Canaccord Genuity Group started coverage on shares of Omada Health in a research report on Tuesday. They issued a “buy” rating and a $27.00 target price on the stock. One equities research analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat.com, Omada Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $23.57.

Omada Health Stock Performance

Shares of Omada Health stock opened at $18.10 on Tuesday. Omada Health has a 1 year low of $14.14 and a 1 year high of $28.40.

About Omada Health

Omada’s mission is to bend the curve. Our hope is that, one day, tomorrow’s epidemiologists will notice a bend in disease curves, wonder what might be happening, and conclude that part of that impact has been Omada. As part of that mission, we strive to inspire and enable people to make lasting health changes on their own terms.